TAFLOTAN Adverse Event: Deafness
TAFLOTAN Adverse Event: Deafness is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TAFLOTAN; Product category: Drug; Primary reaction: Deafness.
| Primary drug | TAFLOTAN |
|---|---|
| Product category | Drug |
| Primary reaction | Deafness |
| All reactions | Deafness; Motor dysfunction; Hypoaesthesia; Mental impairment; Muscle spasms |
| Seriousness | Serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Female |
| All drugs reported | TAFLOTAN; EUTHYROX |
| Reporter country | DE |
| Reporter type | 5 |
| Report date | 20140313 |
| Report ID | 10006493 |
$299/mo
Try FDATracker →